MedTrace Logo

The Stork OTC: Collection, Placement & Delivery

NCT02038322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2014-01-16

No results posted yet for this study

Summary

This is a clinical study designed to validate the usability and safety of the over-the-counter (OTC) device by obtaining feedback in a home use environment regarding ease of use of The Stork™ Conception System and the instructions for use. In addition to usability, results for safety, including vaginal

Conditions

  • Safety and Usability

Interventions

DEVICE

The Stork - Conception Aid

Sponsors & Collaborators

  • Rinovum Women's Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael J Pelekanos, OB-GYN · Forbes Regional Hospital

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02038322 on ClinicalTrials.gov